Abstract
The aim of this study was to evaluate the effects of host modulation therapy on periodontal and biochemical parameters. Sixteen rheumatoid arthritis patients newly scheduled for anti-tumour necrosis factor (TNF) therapy were screened for 30 days. Periodontal parameters (clinical attachment level, probing pocket depth, bleeding on probing, plaque index and gingival index) as well as salivary and gingival crevicular fluid (GCF), interleukin (IL)-1β, IL-8 and monocyte chemoattractant protein-1 (MCP-1) levels of the patients were evaluated at baseline and on the 30th day of therapy. GCF volume, IL-1β and IL-8 levels (p = 0.007, p = 0.017 and p = 0.009, respectively) of the periodontitis patients significantly decreased. Although there was a decrease in all these parameters in healthy patients, it was below statistical significance. Salivary IL-8 and MCP-1 levels significantly decreased in periodontitis patients (p = 0.028 and p = 0.013, respectively), but IL-1β levels remained unchanged. These results suggest that TNF blockers may significantly modify host response in terms of biochemical parameters of the periodontium and may mask significant associations such as those reported between periodontitis and rheumatoid arthritis.
Similar content being viewed by others
References
Armitage, G.C. 1999. Development of a classification system for periodontal diseases and conditions. Annals of Periodontology 4(1): 1–6.
Flemmig, T.F. 1999. Periodontitis. Annals of Periodontology 4(1): 32–38.
Offenbacher, S. 1996. Periodontal diseases: pathogenesis. Annals of Periodontology 1(1): 821–878.
Salvi, G.E., and N.P. Lang. 2005. Host response modulation in the management of periodontal diseases. Journal of Clinical Periodontology 32(Suppl 6): 108–129.
Giannobile, W.V. 2008. Host-response therapeutics for periodontal diseases. Journal of Periodontology 79(8 Suppl): 1592–1600.
Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423(6937): 356–361.
de Pablo, P., et al. 2009. Periodontitis in systemic rheumatic diseases. Nature Reviews Rheumatology 5(4): 218–224.
Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood 87(6): 2095–2147.
Graves, D.T., et al. 1998. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. Journal of Periodontology 69(12): 1419–1425.
Bevilacqua, M.P. 1993. Endothelial-leukocyte adhesion molecules. Annual Review of Immunology 11: 767–804.
Takashiba, S., et al. 1992. Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alpha. Infection and Immunity 60(12): 5253–5258.
Strieter, R.M., et al. 1989. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochemical and Biophysical Research Communications 162(2): 694–700.
Birkedal-Hansen, H. 1993. Role of matrix metalloproteinases in human periodontal diseases. Journal of Periodontology 64(5 Suppl): 474–484.
Pfeilschifter, J., et al. 1989. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. Journal of Bone and Mineral Research 4(1): 113–118.
Tsai, C.C., Y.P. Ho, and C.C. Chen. 1995. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. Journal of Periodontology 66(10): 852–859.
Rollins, B.J. 1996. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Molecular Medicine Today 2(5): 198–204.
Emingil, G., G. Atilla, and A. Huseyinov. 2004. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. Journal of Clinical Periodontology 31(10): 829–834.
Thalayasingam, N., and J.D. Isaacs. 2011. Anti-TNF therapy. Best Practice & Research Clinical Rheumatology 25(4): 549–567.
Elliott, M.J., et al. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344(8930): 1105–1110.
Delima, A.J., et al. 2001. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. Journal of Clinical Periodontology 28(3): 233–240.
Mayer, Y., A. Balbir-Gurman, and E.E. Machtei. 2009. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. Journal of Periodontology 80(9): 1414–1420.
Mayer, Y., et al. 2012. Periodontal condition of patients with auto-immune diseases and the effect of anti-TNF-a therapy. Journal of Periodontology.
Pers, J.O., et al. 2008. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. Journal of Periodontology 79(9): 1645–1651.
Arnett, F.C., et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31(3): 315–324.
Prevoo, M.L., et al. 1995. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38(1): 44–48.
Westergren, A. 1926. The technique of the red cell sedimentation reaction. American Review of Tuberculosis 14: 94–101.
Silness, J., and H. Loe. 1964. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica 22: 121–135.
Loe, H., and J. Silness. 1963. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica 21: 533–551.
Ainamo, J., and I. Bay. 1975. Problems and proposals for recording gingivitis and plaque. International Dental Journal 25(4): 229–235.
Lerner, U.H. 2006. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. Journal of Dental Research 85(7): 596–607.
Buduneli, N., and D.F. Kinane. 2011. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. Journal of Clinical Periodontology 38(Suppl 11): 85–105.
Lamster, I.B., et al. 1985. Lactate dehydrogenase, beta-glucuronidase and arylsulfatase activity in gingival crevicular fluid associated with experimental gingivitis in man. Journal of Periodontology 56(3): 139–147.
Holborow, D., R. Niederman, M. Tonetti, M.A. Cugini, and J.M. Goodson. 1990. Synergistic effects between chlorhexidine mouthwash and tetracycline fibers. Journal of Dental Research 69: 277.
Taylor, P.C., et al. 2000. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis and Rheumatism 43(1): 38–47.
Tak, P.P., et al. 1996. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis and Rheumatism 39(7): 1077–1081.
Charles, P., et al. 1999. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. Journal of Immunology 163(3): 1521–1528.
Savioli, C., et al. 2012. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. Journal of Clinical Rheumatology 18(4): 180–184.
Scher, J.U., et al. 2012. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis and Rheumatism 64(10): 3083–3094.
Ustun, K., et al. 2013. Periodontal disease in patients with psoriatic arthritis. Inflammation.
Acknowledgments
The authors thank Digdem Taskaya, Application Specialist, BD Biosciences, for her valuable support during the biochemical analyses and Yrd.Doç.Dr. Seval Kul for the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Üstün, K., Erciyas, K., Kısacık, B. et al. Host Modulation in Rheumatoid Arthritis Patients with TNF Blockers Significantly Decreases Biochemical Parameters in Periodontitis. Inflammation 36, 1171–1177 (2013). https://doi.org/10.1007/s10753-013-9652-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-013-9652-9